review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Boopathy Ramakrishnan | |
Pradman K Qasba | |||
Elizabeth Boeggeman | |||
P2860 | cites work | Glycosylation of recombinant antibody therapeutics | Q36132495 |
Drug-conjugated monoclonal antibodies for the treatment of cancer | Q36222587 | ||
Antibody targeted drugs as cancer therapeutics | Q36373103 | ||
Mutant glycosyltransferases assist in the development of a targeted drug delivery system and contrast agents for MRI | Q36439174 | ||
Therapeutic antibodies--delivering the promise? | Q36528056 | ||
The impact of glycosylation on the biological function and structure of human immunoglobulins. | Q36618276 | ||
The N-linked sugar chains of human immunoglobulin G: their unique pattern, and their functional roles | Q36894895 | ||
Further studies on the site-specific protein modification by microbial transglutaminase | Q40779928 | ||
A single point mutation reverses the donor specificity of human blood group B-synthesizing galactosyltransferase | Q44279217 | ||
A chemoenzymatic approach toward the rapid and sensitive detection of O-GlcNAc posttranslational modifications | Q44704206 | ||
In vitro galactosylation of human IgG at 1 kg scale using recombinant galactosyltransferase | Q46723270 | ||
Novel method for in vitro O-glycosylation of proteins: application for bioconjugation | Q46937742 | ||
Tumor-Specific Novel Taxoid−Monoclonal Antibody Conjugates | Q59183296 | ||
Labeling of the oligosaccharide moieties of immunoglobulins | Q70179747 | ||
Development of potent monoclonal antibody auristatin conjugates for cancer therapy | Q73460183 | ||
Structural basis of carbohydrate transfer activity by human UDP-GalNAc: polypeptide alpha-N-acetylgalactosaminyltransferase (pp-GalNAc-T10) | Q83227690 | ||
Dynamic association between the catalytic and lectin domains of human UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferase-2 | Q24301958 | ||
Structure-based design of beta 1,4-galactosyltransferase I (beta 4Gal-T1) with equally efficient N-acetylgalactosaminyltransferase activity: point mutation broadens beta 4Gal-T1 donor specificity | Q27638603 | ||
Click Chemistry: Diverse Chemical Function from a Few Good Reactions | Q28204398 | ||
Improving the efficacy of antibody-based cancer therapies | Q28208361 | ||
The donor substrate specificity of the human beta 1,3-glucuronosyltransferase I toward UDP-glucuronic acid is determined by two crucial histidine and arginine residues | Q28216354 | ||
Introducing genetically encoded aldehydes into proteins | Q28298867 | ||
Mutation of arginine 228 to lysine enhances the glucosyltransferase activity of bovine beta-1,4-galactosyltransferase I | Q28586071 | ||
Composition of N-linked carbohydrates from ovalbumin and co-purified glycoproteins | Q30654528 | ||
Direct identification of nonreducing GlcNAc residues on N-glycans of glycoproteins using a novel chemoenzymatic method | Q30830469 | ||
Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics | Q30857760 | ||
Genetically encoded short peptide tags for orthogonal protein labeling by Sfp and AcpS phosphopantetheinyl transferases | Q33283045 | ||
Incorporation of azides into recombinant proteins for chemoselective modification by the Staudinger ligation | Q33896261 | ||
Arming antibodies: prospects and challenges for immunoconjugates | Q34449555 | ||
Targeted drug conjugates: principles and progress | Q34455170 | ||
Engineered antibody fragments and the rise of single domains | Q34650980 | ||
Substrate-induced conformational changes in glycosyltransferases | Q36011052 | ||
Future directions of liposome- and immunoliposome-based cancer therapeutics | Q36045877 | ||
P433 | issue | 3 | |
P304 | page(s) | 520-526 | |
P577 | publication date | 2008-04-22 | |
P1433 | published in | Biotechnology Progress | Q15753227 |
P1476 | title | Site-specific linking of biomolecules via glycan residues using glycosyltransferases | |
P478 | volume | 24 |
Q33995843 | Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2007-2008. |
Q36298206 | Bioconjugation and detection of lactosamine moiety using alpha1,3-galactosyltransferase mutants that transfer C2-modified galactose with a chemical handle |
Q42105089 | Enzyme-mediated methodology for the site-specific radiolabeling of antibodies based on catalyst-free click chemistry |
Q34703755 | Improved synthesis of UDP-2-(2-ketopropyl)galactose and a first synthesis of UDP-2-(2-ketopropyl)glucose for the site-specific linking of biomolecules via modified glycan residues using glycosyltransferases |
Q37405391 | Metabolic glycoengineering: sialic acid and beyond |
Q36108943 | Multiple site-specific in vitro labeling of single-chain antibody |
Q37403530 | Pretargeted PET Imaging Using a Site-Specifically Labeled Immunoconjugate |
Q33441587 | Site specific conjugation of fluoroprobes to the remodeled Fc N-glycans of monoclonal antibodies using mutant glycosyltransferases: application for cell surface antigen detection |
Q34803952 | The impact of enzyme engineering upon natural product glycodiversification |